Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic

With the public debate on the merits of scientific data throughout the COVID-19 pandemic, Bayer announced its support for a new, multi-year Harvard Data Science Initiative (HDSI) research effort. This initiative will explore the public engagement with science, and better understand how to build confidence in the reliability, capability and integrity of scientific data and sound science.

from Breaking World Pharma News https://ift.tt/3gQtzAD